» Articles » PMID: 11145938

Transgenic Rabbits Expressing Human Apolipoprotein(a) Develop More Extensive Atherosclerotic Lesions in Response to a Cholesterol-rich Diet

Overview
Date 2001 Jan 9
PMID 11145938
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

High lipoprotein(a) [Lp(a)] levels constitute an independent risk factor for the development of atherosclerosis. However, the relationship between Lp(a) and atherosclerosis is not fully understood. To examine the effect of Lp(a) on the development of atherosclerosis, we studied transgenic rabbits expressing human apolipoprotein(a) [apo(a)], which was assembled into Lp(a) in the plasma. Human apo(a) transgenic rabbits fed a 0.3% cholesterol diet for 16 weeks had more extensive atherosclerotic lesions than did nontransgenic rabbits, although the cholesterol levels in the plasma of both groups were similarly elevated. Compared with the lesions in control rabbits, the areas of the atherosclerotic lesions in human apo(a) transgenic rabbits were significantly increased in the aorta, the iliac artery, and the carotid artery. Furthermore, human apo(a) transgenic rabbits on a cholesterol-rich diet had a greater degree of coronary atherosclerosis than did control rabbits. Immunohistochemical analysis revealed that human apo(a) was frequently deposited in the atherosclerotic lesions of transgenic rabbits. We conclude that Lp(a) may have proatherogenic effects in the setting of a cholesterol-rich diet in transgenic rabbits.

Citing Articles

Pathological Investigations of Intracranial Atherosclerosis Using Multiple Hypercholesterolemic Rabbit Models.

Tang X, Niimi M, Zhou H, Chen L, Chen Y, Yan H Front Endocrinol (Lausanne). 2022; 13:834207.

PMID: 35712258 PMC: 9196249. DOI: 10.3389/fendo.2022.834207.


Dietary Vitamin C and Age-Induced Lipid and Hormonal Metabolic Changes in a Humanized Mouse Model Not Synthesizing Vitamin C and Producing Lipoprotein(a) [Gulo (-/-); Lp(a)+].

Shi L, Rath M, Niedzwiecki A J Nutr Metab. 2021; 2021:5591697.

PMID: 34221500 PMC: 8221897. DOI: 10.1155/2021/5591697.


Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases.

Lu H, Zhang J, Chen Y, Garcia-Barrio M Cardiovasc Drugs Ther. 2021; 35(3):637-654.

PMID: 33856594 PMC: 8216854. DOI: 10.1007/s10557-021-07175-1.


Genetically Modified Rabbits for Cardiovascular Research.

Fan J, Wang Y, Chen Y Front Genet. 2021; 12:614379.

PMID: 33603774 PMC: 7885269. DOI: 10.3389/fgene.2021.614379.


Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin.

Alfarisi H, Ibrahim M, Mohamed Z, Azahari N, Hamdan A, Che Mohamad C ScientificWorldJournal. 2020; 2020:4503253.

PMID: 33132768 PMC: 7568805. DOI: 10.1155/2020/4503253.